Valion Bio
Manufacturing · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1305 E Houston St Bldg 1 Ste 311, San An...Phone Number
(888) 276-6888Website
www.valionbio.comRevenue
-Stock Symbol
VBIOIndustry
About Valion Bio
Valion Bio is a late-stage biopharmaceutical company focused on developing biologic therapies that activate innate immune pathways for cytoprotection and immune modulation. The companys lead candidate, Entolimod, is a Toll-like receptor 5 agonist with a long development history, supported by regulatory designations such as FDA Fast Track and Orphan Drug status, and ongoing engagement with U.S. government agencies for potential inclusion in the Strategic National Stockpile. Valion Bio is also advancing Entolasta, a next-generation TLR5 agonist, while targeting applications in oncology supportive care, including neutropenia. In addition, its wholly owned subsidiary, Velocity Bioworks, operates as a contract development and manufacturing organization, supporting both internal production and third-party biotechnology clients.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: VBIOShow moreValion Bio Org Chart
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Valion Bio
Sign Up For FreeTo access detailed company insights
Valion Bio is a late-stage biopharmaceutical company focused on developing biologic therapies that activate innate immune pathways for cytoprotection and immune modulation. The companys lead candidate, Entolimod, is a Toll-like receptor 5 agonist with a long development history, supported by regulatory designations such as FDA Fast Track and Orphan... Read More